Thalidomide in POEMS syndrome: Case report

被引:56
作者
Sinisalo, M
Hietaharju, A
Sauranen, J
Wirta, O
机构
[1] Tampere Univ Hosp, Dept Internal Med, FIN-33521 Tampere, Finland
[2] Tampere Univ Hosp, Dept Neurol, Tampere, Finland
关键词
D O I
10.1002/ajh.20051
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We report a patient with incapacitating POEMS syndrome characterized by serum monoclonal protein, polyneuropathy, organomegaly, endocrinopathy, mesanglocapillary glomerulonephritis, massive ascites formation, and pulmonary hypertension. A dramatic improvement in the clinical condition occurred after administration of thalidomide, a drug with known anti-angiogenetic, anti-proliferative, and anti-cytokine properties. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:66 / 68
页数:3
相关论文
共 15 条
[1]   All-trans-retinoic acid in poems syndrome - Therapeutic effect associated with decreased circulating levels of proinflammatory cytokines [J].
Authier, FJ ;
Belec, L ;
Levy, Y ;
Lefaucheur, JP ;
Defer, GL ;
Degos, JD ;
Gherardi, RK .
ARTHRITIS AND RHEUMATISM, 1996, 39 (08) :1423-1426
[2]   PLASMA-CELL DYSCRASIA WITH POLYNEUROPATHY, ORGANOMEGALY, ENDOCRINOPATHY, M PROTEIN, AND SKIN CHANGES - THE POEMS SYNDROME - REPORT ON 2 CASES AND A REVIEW OF THE LITERATURE [J].
BARDWICK, PA ;
ZVAIFLER, NJ ;
GILL, GN ;
NEWMAN, D ;
GREENWAY, GD ;
RESNICK, DL .
MEDICINE, 1980, 59 (04) :311-322
[3]   POEMS syndrome: definitions and long-term outcome [J].
Dispenzieri, A ;
Kyle, RA ;
Lacy, MQ ;
Rajkumar, SV ;
Therneau, TM ;
Larson, DR ;
Greipp, PR ;
Witzig, TE ;
Basu, R ;
Suarez, GA ;
Fonseca, R ;
Lust, JA ;
Gertz, MA .
BLOOD, 2003, 101 (07) :2496-2506
[4]   Role of vascular endothelial growth factor in Physiologic and Pathologic angiogenesis: Therapeutic implications [J].
Ferrara, N .
SEMINARS IN ONCOLOGY, 2002, 29 (06) :10-14
[5]   Overproduction of proinflammatory cytokines imbalanced by their antagonists in POEMS syndrome [J].
Gherardi, RK ;
Belec, L ;
Soubrier, M ;
Malapert, D ;
Zuber, M ;
Viard, JP ;
Intrator, L ;
Degos, JD ;
Authier, FJ .
BLOOD, 1996, 87 (04) :1458-1465
[6]   Low-dose thalidomide therapy for refractory cutaneous lesions of lupus erythematosus [J].
Housman, TS ;
Jorizzo, JL ;
McCarty, MA ;
Grummer, SE ;
Fleischer, AB ;
Sutej, PG .
ARCHIVES OF DERMATOLOGY, 2003, 139 (01) :50-54
[7]   High-dose therapy and autologous blood stem cell transplantation in POEMS syndrome [J].
Jaccard, A ;
Royer, B ;
Bordessoule, D ;
Brouet, JC ;
Fermand, JP .
BLOOD, 2002, 99 (08) :3057-3059
[8]   Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection [J].
Jacobson, JM ;
Spritzler, J ;
Fox, L ;
Fahey, JL ;
Jackson, JB ;
Chernoff, M ;
Wohl, DA ;
Wu, AW ;
Hooton, TM ;
Sha, BE ;
Shikuma, CM ;
MacPhail, LA ;
Simpson, DM ;
Trapnell, CB ;
Basgoz, N .
JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (01) :61-67
[9]   Pulmonary hypertension in POEMS syndrome - A new feature mediated by cytokines [J].
Lesprit, P ;
Godeau, B ;
Authier, FJ ;
Soubrier, M ;
Zuber, M ;
Larroche, C ;
Viard, JP ;
Wechsler, B ;
Gherardi, R .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 157 (03) :907-911
[10]  
MODESTOSEGONDS A, 1995, CLIN NEPHROL, V43, P342